CDE ID | CDE Description | * 1063 | Site Participant ID (Go To: 422) |
* 422 | EDRN Site ID (Go To: 1270) |
* 1270 | Specimen stored (type) (Go To: 423) |
| Permissible Values (value): | Serum (2) |
|
| |
| |
| |
423 | EDRN Protocol ID (Go To: 1064) |
1064 | Site Specimen ID (Go To: 2733) |
* 2733 | Proposed study group (Go To: 1054) |
| Permissible Values (value): | Set C Cases: Lung cancer (prospective) (21) |
|
| | Set C Controls: High Risk (prospective) (23) |
|
| | Set C Controls: Other cancers (prospective) (25) |
|
1054 | Specimen collection date (MM/DD/YYYY): (Go To: 578) |
578 | Age at specimen collection (Go To: 747) |
747 | Additive used in blood collection? (Go To: 751) |
| Permissible Values (value): | EDTA (1) |
|
| |
| |
| |
| |
| |
751 | Original blood sample was collected as: (Go To: 1248) |
| Permissible Values (value): | Fasting (1) |
|
| |
| |
1248 | Was sample collected and processed according to Standard Operating Procedures (SOPs)? (Go To: 945) |
| Permissible Values (value): | No (0) |
|
| |
| |
945 | Number of freeze-thaws: (Go To: 1247) |
1247 | Time from blood draw to first freeze: (value) (Go To: 1097) |
1097 | Comments (do not include any participant identifiers) (Go To: End of Form) |